Pretreatment dosimetry in HCC radioembolization with 90Y glass microspheres cannot be invalidated with a bare visual evaluation of 99mTc-MAA uptake of colorectal metastases treated with resin microspheres

Journal of Nuclear Medicine

Volumn 55, Issue 7, 2014, Pages 1215-1216

  Chiesa, Carlo ^b   Lambert, Bieke ^b   Maccauro, Marco ^b   Ezziddin, Samer ^b   Ahmadzadehfar, Hojjat ^b   Dieudonné, Arnaud ^b   Cremonesi, Marta ^b   Konijnenberg, Mark ^b   Lassmann, Michael ^b   Pettinato, Cinzia ^b   Strigari, Lidia ^b   Vanderlinden, Bruno ^b   Crippa, Flavio ^a   Flamen, Patrick ^b   Garin, Etienne ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MACROSALB TC 99M; MICROSPHERE Y 90; RADIOACTIVE MICROSPHERE; UNCLASSIFIED DRUG; MICROSPHERE;

ARTIFICIAL EMBOLISM; CANCER RADIOTHERAPY; COLORECTAL LIVER METASTASIS; CONTRAST TO NOISE RATIO; DOSE RESPONSE; DOSIMETRY; HUMAN; LETTER; LIVER CELL CARCINOMA; PERFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIOACTIVITY; RADIOBIOLOGY; RADIOEMBOLIZATION; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; TUMOR SCINTISCANNING; COLORECTAL TUMOR; FEMALE; LIVER NEOPLASMS; MALE; METABOLISM; PATHOLOGY;

COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 84904127893     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.129361     Document Type: Letter

References (10)

1. 90Y- microspheres. J Nucl Med. 2013;54:516-522.
2. Mazzaferro V, Sposito C, Bhoori S, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocarcinoma: a phase II study. Hepatology. 2013;57:1826-1837.
3. Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med. 2010;40:105-121.
4. 90Y resin microspheres in hepatic radioembolization. J Nucl Med. 2013;54:1294-1301.
5. Flamen P, Vanderlinden B, Delatte P, et al. Corrigendum: multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres. Phys Med Biol. 2014;59:2549.
6. Ho S, Lau WY, Leung TWT, et al. Clinical evaluation of the partition model for estimate radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med. 1997;24:293-298. (Pubitemid 27165858)
7. 90Y radioembolization. J Nucl Med. 2012;53:559-566.
8. Bilbao JI, de Martino A, de Luis E, et al. Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol. 2009;32:727-736.
9. 90Y glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med. 2014;55:135-140.
10. 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept. Eur J Nucl Med Mol Imaging. 2013;40:1057-1068.